{"id":483108,"date":"2021-04-28T07:08:16","date_gmt":"2021-04-28T11:08:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/"},"modified":"2021-04-28T07:08:16","modified_gmt":"2021-04-28T11:08:16","slug":"uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","title":{"rendered":"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LEXINGTON, Mass. and AMSTERDAM, The Netherlands, April  28, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nWb0OaiKAh2MVz47nBz4kc7JAW6qgAeGKieOdeIFddHeLBT7letkMz2a2PuuVUHTv57CR8jAf9rZsfz7A5VFjA==\" rel=\"nofollow noopener\" target=\"_blank\">uniQure N.V.<\/a> (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that five data presentations, of which two are oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Virtual 2021 Annual Meeting being held May 11-14.<\/p>\n<p align=\"justify\">&#8220;Our presentations at ASGCT showcase our gene therapy expertise in hemophilia and Huntington\u2019s disease, as well as advantages of the AAV5 vector in dosing through pre-existing neutralizing antibodies,\u201d stated Ricardo Dolmetsch, Ph.D.president of research and development at uniQure. \u201cIn addition, we look forward to presenting preclinical data demonstrating the potential of the miQURE technology used in our CNS product candidates to be effective in liver-based diseases as well.\u201d<\/p>\n<p align=\"justify\">Specific details on uniQure\u2019s presentations at ASGCT include:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Clinical Outcomes in Patients With and Without Pre-existing Neutralizing Antibodies to the Vector: 6-Month Data from the Phase 3 HOPE-B Gene Therapy Trial of Etranacogene Dezaparvovec <\/em>(Abstract #88)<br \/><strong>Oral Session Title: <\/strong>Immune Responses to AAV Vectors<br \/><strong>Date and Time: <\/strong>Wednesday, May 12, 6:15 \u2013 6:30 p.m. EDT<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>First Proof-of-Concept of miQURE<\/em><br \/>\n          <sup><br \/>\n            <em>TM<\/em><br \/>\n          <\/sup><br \/>\n          <em>\u00a0Based Gene Targeting in the Liver: Lipid Lowering and Atherosclerosis Suppression by AAV-miQURE<\/em><br \/>\n          <sup><br \/>\n            <em>TM<\/em><br \/>\n          <\/sup><br \/>\n          <em>-Mediated ANGPTL3 Targeting <\/em>(Abstract #156)<br \/><strong>Oral Session Title: <\/strong>Cardiovascular and Pulmonary Gene Therapy<br \/><strong>Date and Time:<\/strong> Thursday, May 13, 6:30 \u2013 6:45 p.m. EDT<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Lowering the Pathogenic Exon 1 HTT Fragment by AAV5-miHTT Gene Therapy <\/em>(Abstract #446)<br \/><strong>Poster Session Title: <\/strong>Oligonucleotide Therapeutics<br \/><strong>Date and Time: <\/strong>Tuesday, May 11, 8:00 \u2013 10:00 a.m. EDT<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Presence of Pre-Existing Anti-Adeno-Associated Virus (AAV) Serotype 5 Neutralizing Antibodies (NABs) in Serum of Huntington Disease (HD) Patients Was Not Associated with Detectable Anti-AAV5 Nabs in Cerebrospinal Fluid (CSF) <\/em>(Abstract #736)<br \/><strong>Poster Session Title: <\/strong>Immunological Aspects of Gene Therapy and Vaccines<br \/><strong>Date and Time: <\/strong>Tuesday, May 11, 8:00 \u2013 10:00 a.m. EDT<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Title: <\/strong><br \/>\n          <em>Dynamics, Features and Cross-Reactivity of IgG Pool Induced after AAV5 Gene Therapy for Hemophilia B <\/em> (Abstract #741)<br \/><strong>Poster Session Title: <\/strong>Immunological Aspects of Gene Therapy and Vaccines<br \/><strong>Session Date and Time: <\/strong>Tuesday, May 11, 8:00 \u2013 10:00 a.m. EDT<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About uniQure <\/strong><br \/>\n        <br \/>uniQure is delivering on the promise of gene therapy \u2013 single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nWdb6tXsoSs5TQnrimZA3O_29RrEoSKiDQh6hovGhDuM805G0bbw9HDicdKhRB5UfeIYKiJXFQOqgxsDPECvSbraYbWG0mv1jb_2zhBYDGY=\" rel=\"nofollow noopener\" target=\"_blank\">pipeline<\/a> of proprietary gene therapies to treat patients with hemophilia B, Huntington&#8217;s disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pLvsaIYA30MVWjkRpHiYwlGSILpccYwUeRqZ3Gou_hXlQ1Y-rdrOX35CCZOPvOKj-QXYnpS0j7ExZ1AOfsxV3g==\" rel=\"nofollow noopener\" target=\"_blank\">www.uniQure.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>uniQure Contacts:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:33%;width:33%;min-width:33%\">\n            <strong>FOR INVESTORS:<\/strong>\n          <\/td>\n<td style=\"max-width:34%;width:34%;min-width:34%\">\u00a0<\/td>\n<td style=\"max-width:33%;width:33%;min-width:33%\">\n            <strong>FOR MEDIA:<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td>\n            <strong>Maria E. Cantor<\/strong>\n          <\/td>\n<td>\n            <strong>Chiara Russo<\/strong>\n          <\/td>\n<td>\n            <strong>Tom Malone<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Direct: 339-970-7536<\/td>\n<td>Direct: 617-306-9137<\/td>\n<td>Direct: 339-970-7558<\/td>\n<\/tr>\n<tr>\n<td>Mobile: 617-680-9452<\/td>\n<td>Mobile: 617-306-9137<\/td>\n<td>Mobile:339-223-8541<\/td>\n<\/tr>\n<tr>\n<td>\n            <a href=\"mailto:m.cantor@uniQure.com\" rel=\"nofollow noopener\" target=\"_blank\">m.cantor@uniQure.com<\/a>\n          <\/td>\n<td>\n            <a href=\"mailto:c.russo@uniQure.com\" rel=\"nofollow noopener\" target=\"_blank\">c.russo@uniQure.com<\/a>\n          <\/td>\n<td>\n            <a href=\"mailto:t.malone@uniQure.com\" rel=\"nofollow noopener\" target=\"_blank\">t.malone@uniQure.com<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/7ac3e362-7209-4492-beda-f163db26bf77\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass. and AMSTERDAM, The Netherlands, April 28, 2021 (GLOBE NEWSWIRE) &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that five data presentations, of which two are oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Virtual 2021 Annual Meeting being held May 11-14. &#8220;Our presentations at ASGCT showcase our gene therapy expertise in hemophilia and Huntington\u2019s disease, as well as advantages of the AAV5 vector in dosing through pre-existing neutralizing antibodies,\u201d stated Ricardo Dolmetsch, Ph.D.president of research and development at uniQure. \u201cIn addition, we look forward to presenting preclinical data demonstrating the potential of the miQURE technology used in our &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-483108","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass. and AMSTERDAM, The Netherlands, April 28, 2021 (GLOBE NEWSWIRE) &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that five data presentations, of which two are oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Virtual 2021 Annual Meeting being held May 11-14. &#8220;Our presentations at ASGCT showcase our gene therapy expertise in hemophilia and Huntington\u2019s disease, as well as advantages of the AAV5 vector in dosing through pre-existing neutralizing antibodies,\u201d stated Ricardo Dolmetsch, Ph.D.president of research and development at uniQure. \u201cIn addition, we look forward to presenting preclinical data demonstrating the potential of the miQURE technology used in our &hellip; Continue reading &quot;uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T11:08:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting\",\"datePublished\":\"2021-04-28T11:08:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\"},\"wordCount\":446,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\",\"name\":\"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=\",\"datePublished\":\"2021-04-28T11:08:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk","og_description":"LEXINGTON, Mass. and AMSTERDAM, The Netherlands, April 28, 2021 (GLOBE NEWSWIRE) &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that five data presentations, of which two are oral presentations, will be delivered at the American Society of Gene and Cell Therapy (ASGCT) Virtual 2021 Annual Meeting being held May 11-14. &#8220;Our presentations at ASGCT showcase our gene therapy expertise in hemophilia and Huntington\u2019s disease, as well as advantages of the AAV5 vector in dosing through pre-existing neutralizing antibodies,\u201d stated Ricardo Dolmetsch, Ph.D.president of research and development at uniQure. \u201cIn addition, we look forward to presenting preclinical data demonstrating the potential of the miQURE technology used in our &hellip; Continue reading \"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-28T11:08:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting","datePublished":"2021-04-28T11:08:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/"},"wordCount":446,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/","name":"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=","datePublished":"2021-04-28T11:08:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTE4MiM0MTQzMjY0IzIwODA0MDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/uniqure-announces-presentations-at-upcoming-american-society-of-gene-and-cell-therapy-asgct-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"uniQure Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=483108"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483108\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=483108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=483108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=483108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}